Efficacy of Dual Antiplatelet Therapy After Lacunar versus Non-Lacunar Syndromes in the POINT Trial

被引：0
|
作者：
Heidari, Parisa
Seitz, Alison
Liberman, Ava
Navi, Babak B.
Kamel, Hooman
机构：
来源：
STROKE | 2024年 / 55卷
关键词：
D O I：
10.1161/str.55.suppl_1.WP238
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WP238
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of single versus dual antiplatelet therapy in carotid artery stenting
    Marcaccio, Christina L.
    Patel, Priya B.
    Rastogi, Vinamr
    Stangenberg, Lars
    Liang, Patric
    Wyers, Mark C.
    Jim, Jeffrey
    Schneider, Peter A.
    Schermerhorn, Marc L.
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (05) : 1434 - +
  • [42] Presence of Infarct Predicts Recurrence and Efficacy of Dual Antiplatelet Therapy: A Post-Hoc Analysis of the POINT Trial.
    Kvernland, Alexandra
    Rostanski, Sara K.
    Mac Grory, Brian
    De Havenon, Adam H.
    Liberman, Ava
    Kim, Anthony S.
    Easton, J. Donald
    Johnston, S. Claiborne
    Yaghi, Shadi
    STROKE, 2021, 52
  • [43] Dual antiplatelet therapy versus single antiplatelet therapy after transaortic valve replacement: Meta-analysis
    Alrifai, Abdulah
    Soud, Mohamad
    Kabach, Amjad
    Jobanputra, Yash
    Masrani, Abdulrahman
    El Dassouki, Saleh
    Alraies, M. Chadi
    Fanari, Zaher
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (06) : S47 - S52
  • [44] Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
    Alfredsson, Joakim
    Neely, Benjamin
    Neely, Megan L.
    Bhatt, Deepak L.
    Goodman, Shaun G.
    Tricoci, Pierluigi
    Mahaffey, Kenneth W.
    Cornel, Jan H.
    White, Harvey D.
    Fox, Keith A. A.
    Prabhakaran, Dorairaj
    Winters, Kenneth J.
    Armstrong, Paul W.
    Ohman, E. Magnus
    Roe, Matthew T.
    HEART, 2017, 103 (15) : 1168 - 1176
  • [45] Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting
    Eisen, Alon
    Bhatt, Deepak L.
    HEART, 2017, 103 (11) : 871 - 884
  • [46] Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?
    Niazi, Asfandyar K.
    DiNicolantonio, James J.
    Lavie, Carl J.
    O'Keefe, James H.
    Meier, Pascal
    Bangalore, Sripal
    CARDIOLOGY, 2013, 126 (04) : 233 - 243
  • [47] Ticagrelor Monotherapy Following Short Dual Antiplatelet Therapy versus 12-Month Dual Antiplatelet Therapy after Percutaneous Coronary
    Joseph, Meghna
    Krishna, Mrinal Murali
    Ezenna, Chidubem
    Goldsweig, Andrew
    CIRCULATION, 2024, 150
  • [48] Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial
    Zhou, Zien
    Xia, Chao
    Carcel, Cheryl
    Yoshimura, Sohei
    Wang, Xia
    Delcourt, Candice
    Malavera, Alejandra
    Chen, Xiaoying
    Mair, Grant
    Woodward, Mark
    Chalmers, John
    Demchuk, Andrew M.
    Lindley, Richard I.
    Robinson, Thompson G.
    Parsons, Mark W.
    Wardlaw, Joanna M.
    Anderson, Craig S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (03) : 783 - 793
  • [49] Mortality and cancer after 12 versus 30 months dual antiplatelet therapy
    Serebruany, Victor L.
    Kim, Moo Hyun
    Cabrera-Fuentes, Hector A.
    Lee, Kwangmin
    Cho, Young Rak
    Park, Kyungil
    Park, Tae Ho
    Kim, Young Dae
    Yoon, Sung-Cheol
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (05) : 934 - 939
  • [50] Evaluation of Efficacy of Mechanical versus Thermal Therapy Hemostasis in Non-Variceal Upper Gastrointestinal Bleed Patients on Dual Antiplatelet Therapy
    Karna, Rahul
    Hans, Bandhul
    Chaudhary, Dhruv
    Dhawan, Manish
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S299 - S300
12345